Navigation Links
Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Company's Home Health Care Business
Date:8/22/2007

Ability of Masimo SET pulse oximetry technology to significantly reduce false alarms without missing true hypoxic events cited as the reason for

choosing Masimo over all other technologies

IRVINE, Calif., Aug. 22 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Read-Through Motion and Low Perfusion pulse oximetry, today announced a partnership with Apria Healthcare to provide pulse oximetry products and accessories for Apria's home health care business. Apria Healthcare is America's leading provider of integrated home health care products and services, offering a comprehensive range of home respiratory therapy, diabetic supplies, medications and equipment, home infusion therapy and home medical equipment services.

Apria conducted a competitive bid in which Masimo was selected due to the superior clinical performance of its proprietary Masimo SET pulse oximetry technology, which significantly enhances the ability of Apria's customers to detect hypoxic events in the home care setting. This will provide patients and caregivers with reliable warnings of these instances where blood oxygen levels begin to drop, which in turn will lead to expedient intervention and the delivery of the appropriate level of care.

Masimo SET has been clinically proven in more than 100 independent clinical and laboratory studies to provide the most trustworthy continuous noninvasive arterial blood oxygen saturation and pulse rate measurements even under the most difficult clinical conditions, including patient motion and low peripheral perfusion. These studies prove Masimo SET delivers improvements in outcomes, safety and efficiency by providing accurate measurement of arterial oxygen satuaration and pulse rate and significantly reducing false alarms while improving detection of true events.

Joe E. Kiani, Chairman & CEO of Masimo, stated, "We are happy that Apria has chosen Masimo SET technology to help kee
'/>"/>

SOURCE Masimo Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Web-based reporting credited with states top healthcare ranking
2. Visions: Preizler offers insurers perspective on healthcare IT
3. Federal bill would set healthcare IT standards
4. IRS ruling could speed healthcare technology adoption
5. Bill would provide federal aid for healthcare IT
6. DHC 2007: Hayden says technology creates magic moment for healthcare delivery
7. Digital Healthcare Conference 2007: Mounting obstacles for health IT
8. Georgia healthcare system to install GEs radio frequency ID
9. GE Healthcare leads compact ultrasound market
10. CIO Leadership Series: Greg Smith, Wheaton Franciscan Healthcare
11. Merge Healthcare suffers $258M loss in `06
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...ewswire-FirstCall/ -- Pharmaxis,Ltd (AXS: PXS; Nas...ly,Report to Shareholders on the afternoon of Wedn... investor teleconference the following morning to,... The teleconference will be on Thursday 16th Octo... 5.30pm U.S. East Coast, 2.30pm U.S. West Coast).,...
(Date:10/10/2008)...rMatrix Cardiovascular, Inc., an,Atlanta-based com...,extracellular matrix (ECM(TM)) biomaterial device... damaged cardiovascular tissue, today announced,th...er, will present data,on the company,s next genera...r Cardiovascular Therapeutics (TCT) 2008 conferenc...
(Date:10/10/2008)...ire-FirstCall/ -- XTL,Biopharmaceuticals Ltd. (Nas...ts Extraordinary General Meetings ("EGMs") held ea...ows: all of the resolutions passed,and Jennifer L....ternal,Directors of the Company until October 10, ...nsists of Mr. Zuerblis, Ms. Good and Dr. William K...
(Date:10/10/2008)... Milestone in its Ofatumumab ...ctober 10 /- Genmab A/S,(OM...ilestone for,ofatumumab (HuMax-CD20(R)) under the ...SK). A milestone payment of approximately DKK 29 m...ed by the first patient,receiving treatment in the...
Breaking Biology Technology:CorMatrix Cardiovascular to Present Data on Its Next Generation ECM Technology(TM) at Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, D.C. 2Genmab Reaches Milestone in Ofatumumab Collaboration 2
...rian, Inc. , Introduction , Rit...ug shown to be effective in the treatment of anxie...pamine D2 receptor antagonist. 2 These two compou... of the Varian 1200L LC/MS/MS in selected reaction...o be a useful tool in the quantitation of low leve...
... Houston, TX , Introduction , A ...titation of the plasma levels oxybutynin obtained ...rinary tract using a urethra suppository mode of a...t disease is a major health problem in the U.S. an... population. Urinary incontinence accounts for ove...
... responsible for most of the biological effects in... and allergic type responses. T lymphocytes are a ...n-specific receptors on their cell surface to allo...main subsets of T lymphocytes, distinguished by th...and CD8. T lymphocytes expressing CD4 are also kno...
...n , Formation of new blood vessels is fu...ses and has therefore been the focus of many drug ...od vessel development is a significant event in th...mplicated in wound healing, retinopathy and macula...s to quantify the degree of blood vessel formation...
Other Biology Technology:Femtogram Sensitivity of the Antipsychotic Drugs Raclopride and Ritanserin Using a Varian 1200L LC/MS/MS 2Quantitation of Oxybutynin in Rabbit Plasma Using the Varian 1200L LC/MS/MS System 2Quantitation of Oxybutynin in Rabbit Plasma Using the Varian 1200L LC/MS/MS System 3Th1 and Th2 Balance, Regulation, and Involvement in Disease 2An Image-Based Assay of Endothelial Cell Tube Formation as a Model of Angiogenesis 2An Image-Based Assay of Endothelial Cell Tube Formation as a Model of Angiogenesis 3An Image-Based Assay of Endothelial Cell Tube Formation as a Model of Angiogenesis 4
(Date:10/10/2008)...ied stem cells with the capacity to build fat, acc...e journal Cell, a Cell Press publication. Althou...themselves, transplants of the progenitor cells is...ore normal fat tissue in animals that are otherwis...o the causes of obesity, a condition characterized...
(Date:10/10/2008)...technology have shaped not only how we find or sha.... A project just funded by the National Institutes...n to the next level. , The University of Michiga...olecular data needed to develop computer programs ...ates. The data will be housed in a Web-based resou...
(Date:10/10/2008)...stigators from the Herman B Wells Center for Pedia...Medicine are focusing on a family of blood protein...xic effects of chemotherapy in children and adults...lopment of targeted therapies for leukemia, multip... researchers, led by Kristin T. Chun, Ph.D., assis...
(Date:10/10/2008)...sh, Gasterosteus aculeatus , is one of the most t...een a particularly useful model for understanding ...d morphology caused by different ecological situat...lecular and genetic to developmental and morpholog..., it has proven far more complex than even imagine...
Breaking Biology News(10 mins):Fat-regenerating 'stem cells' found in mice 2New data resource to advance computer-aided drug design 2On the trail of a targeted therapy for blood cancers 2Fitness in a changing world 2Fitness in a changing world 360 Specialty Chemical Fine Chemical 26 Custom Synthesis Providers Will Exhibit at Pharma ChemOutsourcing on September 8 9 in New Jersey 5665 160 Specialty Chemical Fine Chemical 26 Custom Synthesis Providers Will Exhibit at Pharma ChemOutsourcing on September 8 9 in New Jersey 5665 2Premier Research Names Anthony Faragasso MD as Executive Director and Global Head of Medical Management and Safety 5663 1Premier Research Names Anthony Faragasso MD as Executive Director and Global Head of Medical Management and Safety 5663 23SBio Inc to Present at the Goldman Sachs Twenty Ninth Annual Global Healthcare Conference 5661 1Access Pharmaceuticals Presents New Data on the Companys Cobalamin 28TM 29 Technology at an International Polymer Therapeutics Symposium 2206 1Access Pharmaceuticals Presents New Data on the Companys Cobalamin 28TM 29 Technology at an International Polymer Therapeutics Symposium 2206 2Access Pharmaceuticals Presents New Data on the Companys Cobalamin 28TM 29 Technology at an International Polymer Therapeutics Symposium 2206 3
...rs and their pollinators have resulted in a specta...inators such as bees, flies or butterflies to visi... have evolved intriguing mechanisms and attractant...ago, researchers discovered that nectars of flower...ounts of amino acids. Recent experiments have show...
...al,detection by factor of 10 billion,New research ...my of,Science finds that tailored nanoparticles kn...as much as 10 billion times. That makes,them about...han,traditional methods. , When,molecules and mate...,interacts in such a way that it allows scientists...
...and the Dana-Farber Cancer Institute report a surp...ood system begins to form not only in the embryo i...rtures the baby in utero. , Meticulous experiments...e supply of hematopoietic (blood-forming) stem cel...pment, are able to generate more blood stem cells ...
... not typical of their species, the first known exa...te terrestrial mammal. The discovery, reported in ...al learning is important for maintaining individua... and reunite over time, like dolphins and whales, ...eli Trust for Elephants in Kenya, the Woods Hole O...
Other Biology News:Study shows nanoshells ideal as chemical nanosensors 2Placenta Is A Rich Source Of Blood Stem Cells 2Elephants imitate truck noises, other animals 2
... quadrupole 1200L sets the new standard for value ...ing the latest technologies and providing tailored...l needs. The Atmospheric Pressure Ionization (API...er provide superior selectivity and sensitivity fo...
Human beta IG-H3 MAb (Clone 348506) Keywords: BIGH3, betaIG-H3 Protein Family: Extracellular Matrix Molecules
Catalase (Control)
Human RELT/TNFRSF19L Affinity Purified Polyclonal Ab
Biology Products: